The Size of the Middle East & Africa Atrial Fibrillation Surgery Market is valued at USD 0.11 billion in 2022 and is projected to reach USD 0.24 billion by 2027, increasing at a CAGR of 16.2% during the forecast period 2022 to 2027.
Atrial Fibrillation is an abnormal rhythm or quivering of the heart caused by irregular beating of the atria. This condition of heart can lead to stroke, blood clots, heart failure and other heart related issues. The symptoms include fainting, chest pain, shortness of breath and heart palpitations.
Atrial fibrillation, if left untreated doubles the risk of heart related deaths and stokes in humans. Treatment for atrial fibrillation includes rhythm control, heart rate control, preventing heart failure and blood clots. But treatment and medication doesn’t work in all cases. In that case, surgical procedure is conducted to destroy the heart tissue in the area that is causing erratic electrical signals and restore the heart to a normal rhythm either by using catheters or during an open heart surgery.
Growing number of atrial fibrillation cases all over the globe is the major factor driving this market. Lower treatment costs and reimbursement policies are expected to drive the market. Favourable regulations and increasing preference for surgeries are also driving the market. However, lack of awareness about surgeries or health risks posed by atrial fibrillation among the people suffering from the issue and availability of several pharmaceutical alternatives are restraining the market.
This research report on the Middle East &Africa Atrial Fibrillation Surgery Market has been segmented and sub-segmented into the following categories
By Surgical Procedure:
By Product :
On the basis of region, the Middle East region shows significant growth due to the growing awareness of people in this region and growth in Africa region is somewhat slow due to the presence of many low and middle income countries in this region.
Noteworthy Companies dominating the Middle East & Africa Atrial Fibrillation Surgery Market profiled in the Report are Biosense Webster, Inc., Boston Scientific Corporation, St. Jude Medical, Inc., Articure, Inc., Medtronic, Inc., Cardima, Inc. Cardiofocus, Inc., nContact, Inc., and Biotronik SE & Co.,
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Surgical Procedure
5.1.2 Catheter Ablation Procedures
5.1.3 Surgical Ablation/Maze Procedures
5.1.4 Y-o-Y Growth Analysis, By Surgical Procedure
5.1.5 Market Attractiveness Analysis, By Surgical Procedure
5.1.6 Market Share Analysis, By Surgical Procedure
5.2.2 Catheter Ablation Device
5.2.3 Surgical Ablation Device
5.2.4 Y-o-Y Growth Analysis, By Product
5.2.5 Market Attractiveness Analysis, By Product
5.2.6 Market Share Analysis, By Product
6. Geographical Analysis
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
126.96.36.199 By Geographical Area
188.8.131.52 By Surgical Procedure
184.108.40.206 By Product
6.1.4 Market Attractiveness Analysis
220.127.116.11 By Geographical Area
18.104.22.168 By Surgical Procedure
22.214.171.124 By Product
6.1.5 Market Share Analysis
126.96.36.199 By Geographical Area
188.8.131.52 By Surgical Procedure
184.108.40.206 By Product
7.1 PESTLE analysis
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Medtronic, Inc.
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Biosense Webster, Inc.
8.3 Boston Scientific CorporationInternational
8.4 St. Jude Medical, Inc.
8.5 Cardiofocus, Inc.
8.6 Atricure, Inc.
8.7 Carima, Inc.
8.8 Ncontact, Inc.
8.9 Biotroik Se & Co.Kg
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, Collaborations, and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
a) List of Tables
b) List of Figures
Talk to our analyst and get customised report done according to your research needs
Check if you can avail any discount. Submit your details and our team will get back to you.
Request to avail a free sample report that reflects this market and its growth.